Latest News & Updates of Loncom Pharma

CPHI Shanghai 2025: Biocom Pharma management team led a strong sales delegation to this prestigious gathering. Our booth attracted numerous visitors, facilitating deep exchanges and collaborative discussions with industry peers, experts, and partners, culminating in a highly fruitful conclusion.

Shandong Loncom Pharmaceutical Co., Ltd. has achieved a major regulatory milestone by obtaining the Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its Sorafenib Tosylate active pharmaceutical ingredient (API). This accomplishment h

IntroductionIn the realm of pharmaceutical advancements, the development of effective and safe active pharmaceutical ingredients (APIs) is crucial for improving patient outcomes. Among the latest innovations, Linzagolix Choline has emerged as a promising API, particularly in the treatment of endomet

Season's Greetings from Shandong Loncom Pharmaceutical As we reflect on a year full of achievements and collaborations, we want to extend our warmest wishes to all of our valued partners. Your trust and support have been vital in helping us advance our mission to improve women's health worldwide.Mer